{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:28:17Z","timestamp":1758040097773,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ahj.2017.07.004","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T01:39:05Z","timestamp":1500082745000},"page":"38-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF)"],"prefix":"10.1016","volume":"192","author":[{"given":"Dragos","family":"Vinereanu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein R.","family":"Al-Khalidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meena P.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia M.","family":"Bahit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea O.","family":"Ciobanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean D.","family":"Pokorney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak Y.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otavio","family":"Berwanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Tajer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2017.07.004_bb0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nrcardio.2016.114","article-title":"Global epidemiology of atrial fibrillation","volume":"13","author":"Rahman","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ahj.2017.07.004_bb0010","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.07.004_bb0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archinte.158.3.229","article-title":"Impact of atrial fibrillation on mortality, stroke, and medical costs","volume":"158","author":"Wolf","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2017.07.004_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.07.004_bb0025","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.113.005451","article-title":"Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry","volume":"129","author":"Oldgren","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.07.004_bb0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/europace\/euu201","article-title":"Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"17","author":"Lip","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2017.07.004_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ahj.2016.03.011","article-title":"A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale","volume":"176","author":"Rao","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2017.07.004_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.ahj.2017.07.004_bb0045","series-title":"Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis","isbn-type":"print","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-19425-7","author":"Harrell","year":"2015","ISBN":"https:\/\/id.crossref.org\/isbn\/9783319194257"},{"key":"10.1016\/j.ahj.2017.07.004_bb0050","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"16","author":"Lip","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2017.07.004_bb0055","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.11-2888","article-title":"The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe","volume":"142","author":"Lip","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ahj.2017.07.004_bb0060","article-title":"The global burden of atrial fibrillation and stroke: a systematic review of the clinical epidemiology of atrial fibrillation in Asia","author":"Bai","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.ahj.2017.07.004_bb0065","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.07.004_bb0070","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2125.2005.02361.x","article-title":"Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?","volume":"59","author":"You","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2017.07.004_bb0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/heartjnl-2016-309832","article-title":"Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation","volume":"103","author":"Camm","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2017.07.004_bb0080","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2016.11.061","article-title":"The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2","volume":"69","author":"Huisman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.07.004_bb0085","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2017.07.004_bb0090","first-page":"208","article-title":"Antithrombotic strategies in atrial fibrillation. The XIX CONAREC Registry","volume":"83","author":"Roel","year":"2015","journal-title":"Rev Argent Cardiol"},{"key":"10.1016\/j.ahj.2017.07.004_bb0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STROKEAHA.107.495036","article-title":"Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians","volume":"39","author":"Gattellari","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2017.07.004_bb0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/qjmed\/hcm016","article-title":"Rules of thumb' or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation","volume":"100","author":"Anderson","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.ahj.2017.07.004_bb0105","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.07.004_bb0110","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2013.12.022","article-title":"'Real-world' antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey","volume":"127","author":"Lip","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2017.07.004_bb0115","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1093\/eurheartj\/ehs071","article-title":"Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation","volume":"33","author":"Hendriks","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.07.004_bb0120","doi-asserted-by":"crossref","first-page":"e000335","DOI":"10.1136\/openhrt-2015-000335","article-title":"Effectiveness of structured, hospital-based, nurse-led atrial fibrillation clinics: a comparison between a real-world population and a clinical trial population","volume":"3","author":"Qvist","year":"2016","journal-title":"Open Heart"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031730203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031730203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:58:11Z","timestamp":1757570291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287031730203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":24,"alternative-id":["S000287031730203X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.07.004","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF)","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}